Date of Publication: May 16, 2020
Source: Global News
On Saturday, Prime Minister Justin Trudeau announced that the first Canadian clinical trials of a potential COVID-19 vaccine have been approved by Health Canada. The research will be conducted at the Canadian Centre for Vaccinology at Dalhousie University. This vaccine, Ad5-nCoV, was approved for Phase 1 human trials in China on March 17. Researchers in other provinces have also reported “promising early results.” Notable ones include Quebec biopharmaceutical company Medcago, University of Saskatchewan’s Vaccine and Infectious Disease Organization-International Vaccine Centre, and a nasal spray vaccine from the University of Waterloo.
Read the full article here: https://globalnews.ca/news/6952634/coronavirus-vaccine-trials-trudeau/?utm_medium=Facebook&utm_source=GlobalNews&fbclid=IwAR3OhN-pQ7Y6kqyDCHiyqcLxOEIWKT18z31109tVEHZAD–Sn6ag4sGe0B0
Summary by: Ming Li